Luminex Signs Up Chinese Distributor for Genetic Tests | GenomeWeb
NEW YORK (GenomeWeb News) – Luminex today said that it has signed an agreement with Mingyuan Medicare Development Company for distribution of its genetic tests in China and Hong Kong.
 
Mingyuan will exclusively distribute a series of newborn screening products based on Luminex’s xMAP technology, which the Austin, Texas-based firm said enables simultaneous analysis of up to 100 assays within a single sample. Mingyuan also will distribute Luminex’s analyzers in China and Hong Kong.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.